Bank Of Montreal Bridge Bio Pharma, Inc. Transaction History

Bank Of Montreal

$192 Billion
Q1 2025

A detailed history of Bank Of Montreal transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 9,309 shares of BBIO stock, worth $308,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,309

Previous 9,176 1.45%

Holding current value

$308,127

Previous $251,000 27.89%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$28.12 - $37.59 $3,739 - $4,999	133 Added 1.45%	9,309 $321,000
Q4 2024 Feb 13, 2025	BUY	$22.35 - $29.5 $6,190 - $8,171	277 Added 3.11%	9,176 $251,000
Q3 2024 Nov 13, 2024	SELL	$23.91 - $31.3 $14,967 - $19,593	-626 Reduced 6.57%	8,899 $226,000
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $18,975 - $25,608	825 Added 9.48%	9,525 $241,000
Q1 2024 May 13, 2024	SELL	$27.35 - $40.45 $492 - $728	-18 Reduced 0.21%	8,700 $269,000
Q4 2023 Feb 08, 2024	SELL	$24.02 - $43.89 $141,477 - $258,512	-5,890 Reduced 40.32%	8,718 $351,000
Q3 2023 Nov 01, 2023	BUY	$16.89 - $35.01 $246,729 - $511,426	14,608 New	14,608 $385,000
Q1 2023 Jun 13, 2024	BUY	$7.17 - $18.55 $37,140 - $96,089	5,180 Added 59.54%	13,880 $230,000
Q2 2022 Aug 11, 2022	BUY	$5.21 - $12.14 $3,271 - $7,623	628 Added 6.7%	10,001 $90,000
Q1 2022 May 12, 2022	SELL	$7.34 - $17.16 $815,378 - $1.91 Million	-111,087 Reduced 92.22%	9,373 $97,000
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $70,612 - $331,409	-6,205 Reduced 4.9%	120,460 $1.76 Million
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $1.67 Million - $2.29 Million	35,626 Added 39.13%	126,665 $6.24 Million
Q2 2021 Aug 12, 2021	BUY	$46.47 - $63.93 $4.23 Million - $5.82 Million	91,039 New	91,039 $5.48 Million

Others Institutions Holding BBIO

# of Institutions

361

Shares Held

185M

Call Options Held

12.8M

Put Options Held

2.09M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.91B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account